483
Patheon Puerto Rico, Inc.FDA 483 - Patheon Puerto Rico, Inc. - October 15, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Patheon part of Thermo Fisher in Manati, PR, was inspected from October 1-15, 2019, and received a Form 483 with two observations. The firm failed to thoroughly review unexplained discrepancies related to Levothyroxine Sodium Tablets and did not follow established production and process control procedures for Janumet Tablets. These issues indicate deficiencies in quality system and production control functions.
Open in Dashboard
ID · c394fc2c-18ad-4917-b21e-8a0d16fe1773